Delivery Order SPE2DB24D2205-SPE2DB26FDSPN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $6,435.48 and a firm fixed price structure. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global...
- The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded a $10,114.72 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30 count) on September 15, 2025, with a completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Cyclosporine 0.05% Eye Emulsion (30 units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by August 7, 2025, reflecting the expedited nature of pharmaceutical supply fulfillment to support federal...
- The Defense Logistics Agency awarded a $1,045.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% eye emulsion (30-count units), with an ultimate completion date of June 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $20,448.66 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 units) under a firm fixed-price contract valued at $3,320.62. This non-set-aside delivery order, with an ultimate completion date of May 7, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a $7,327.31 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the company's broader federal medical...
- The Defense Logistics Agency awarded a $1,216.72 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packaging. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, utilizing no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $2,650.58 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a child contract under its parent company Cencora, Inc. The contract has an ultimate completion date of August 31, 2023 and was awarded on August 30, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSPNDelivery Order
The Defense Logistics Agency awarded a $2,777.72 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) under a firm fixed price contract structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and was competitively awarded. Performance is scheduled for completion by October 22, 2025, with fulfillment occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's prime IDC with DLA serves as a comprehensive global pharmaceutical support vehicle, enabling supply of a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order exemplifies the company's role in supplying specialized pharmaceutical products to the Defense Health Agency and other government healthcare systems through the flexible IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 10/21/25 |